Index of reports
> Cases with Squamous Cell Carcinoma (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Raptiva (Efalizumab) where reactions include squamous cell carcinoma. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Raptiva side effects in 53 year old male
Reported by a physician from Finland on 2012-01-23
Patient: 53 year old male
Reactions: Lymphadenopathy, Squamous Cell Carcinoma, Tongue Neoplasm Malignant Stage Unspecified
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Raptiva
Dosage: 1 dose weekly
Indication: Psoriasis
Start date: 2006-11-09
End date: 2007-06-01
Enbrel
Dosage: 50 mg, weekly
Indication: Psoriasis
Start date: 2007-07-01
Enbrel
Indication: Psoriatic Arthropathy
Other drugs received by patient: Emconcor Comp; Betamethasone Dipropionate / Calcipotriol; Diapam / 00017001 /
Possible Raptiva side effects in 53 year old male
Reported by a physician from Finland on 2011-12-26
Patient: 53 year old male
Reactions: Lymphadenopathy, Squamous Cell Carcinoma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Raptiva
Dosage: unk unk, qwk
Indication: Psoriasis
Start date: 2006-11-09
End date: 2007-06-01
Enbrel
Dosage: 50 mg, weekly
Indication: Psoriasis
Start date: 2007-07-01
Other drugs received by patient: Emconcor Comp; Betamethasone Dipropionate / Calcipotriol; Diapam / 00017001 /
|